Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $45.0000 (-4.76%) ($37.5000 - $45.0000) on Thu. Mar. 7, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 18.91% (three month average) | RSI | 35 | Latest Price | $45.0000(-4.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -15.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -9.455% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -9.455% (StdDev 18.91%) | Hourly BBV | 0 () | Intraday Trend | 20% | | | |
|
1 - 5 Day Possible Target | $5.15(-88.56%) | Resistance Level | $52.91 | 5 Day Moving Average | $42.25(6.51%) | 10 Day Moving Average | $43.57(3.28%) | 20 Day Moving Average | $52.91(-14.95%) | To recent high | -51.4% | To recent low | 246.2% | Market Cap | $886m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |